Inventor · disambiguated record
Juliet Nabakka
Also filed as: NABAKKA JULIET
19 granted patents·7 pending applications·177 citations·filing 2004–2020
94Inventor score
Top patents by PatentIndex Score
26 records- 0196US8338417B2Compounds and compositions as c-kit and PDGFR kinase inhibitorsLI XIAOLIN·Filed 2008·Granted Dec 25, 2012·86 cites·8 claims
- 0289US8569283B2Compounds and compositions as c-Kit kinase inhibitorsMOLTENI VALENTINA·Filed 2012·Granted Oct 29, 2013·12 cites·26 claims
- 0389US8288540B22-heteroarylamino-pyrimidine derivatives as kinase inhibitorsCHIANELLI DONATELLA·Filed 2008·Granted Oct 16, 2012·20 cites·15 claims
- 0489US7678792B2Compositions and methods for modulating c-kit and PDGFR receptorsIRM LLC·Filed 2007·Granted Mar 16, 2010·13 cites·17 claims
- 0582US8293757B25-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitorsMOLTENI VALENTINA·Filed 2008·Granted Oct 23, 2012·6 cites·7 claims
- 0681US9199981B2Compounds and compositions as C-kit kinase inhibitorsYEH VINCE·Filed 2012·Granted Dec 1, 2015·9 cites·26 claims
- 0781US7592349B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Sep 22, 2009·3 cites·14 claims
- 0881US7563894B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Jul 21, 2009·3 cites·10 claims
- 0981US7253164B2Bicyclic compounds and compositions as PDF inhibitorsIRM LLC·Filed 2004·Granted Aug 7, 2007·11 cites·6 claims
- 1078US9023839B2Compounds and compositions as c-kit kinase inhibitorsMOLTENI VALENTINA·Filed 2014·Granted May 5, 2015·3 cites·24 claims
- 1178US7514447B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2006·Granted Apr 7, 2009·2 cites·6 claims
- 1276US8754071B2Compounds and compositions as c-kit kinase inhibitorsMOLENTI VALENTINA·Filed 2013·Granted Jun 17, 2014·5 cites·24 claims
- 1375US7638523B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Dec 29, 2009·1 cites·14 claims
- 1474US8106068B2Compositions and methods for modulating c-kit and PDGFR receptorsLIU ZUOSHENG·Filed 2009·Granted Jan 31, 2012·3 cites·6 claims
- 1567US2009264649A1Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2009·Application pending·0 cites
- 1663US7579363B2Bicyclic compounds and compositions as PDF inhibitorsIRM LLC·Filed 2007·Granted Aug 25, 2009·0 cites·1 claims
- 1755US2013345220A1Compounds and compositions as lxr modulatorsMOLTENI VALENTINA·Filed 2013·Application pending·0 cites
- 1853US8569345B2Compounds and compositions as LXR modulatorsMOLTENI VALENTINA·Filed 2012·Granted Oct 29, 2013·0 cites·6 claims
- 1953US8158662B2Compounds and compositions as LXR modulatorsMOLTENI VALENTINA·Filed 2005·Granted Apr 17, 2012·0 cites·6 claims
- 2051US8278452B2Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitorsCHIANELLI DONATELLA·Filed 2009·Granted Oct 2, 2012·0 cites·14 claims
- 2150US7846949B2Compounds and compositions as LXR modulatorsIRM LLC·Filed 2005·Granted Dec 7, 2010·0 cites·3 claims
- 2247US2010048539A1Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2007·Application pending·0 cites
- 2347US2022127247A1N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of diseaseNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2443US2009062260A1Compounds and compositions as lxr modulatorsIRM LLC·Filed 2006·Application pending·0 cites
- 2541US2015051206A1Compounds and compositions as c-kit kinase inhibitorsLOREN JON·Filed 2012·Application pending·0 cites
- 2641US2015011508A1Compounds and compositions as c-kit kinase inhibitorsLIU XIAODONG·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →